ProShare Advisors’s Rubius Therapeutics, Inc RUBY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-17,933
| Closed | -$98K | – | 2237 |
|
|
2022
Q1 | $98K | Sell |
17,933
-4,762
| -21% | -$26K | ﹤0.01% | 2038 |
|
|
2021
Q4 | $221K | Sell |
22,695
-2,371
| -9% | -$23.1K | ﹤0.01% | 1971 |
|
|
2021
Q3 | $448K | Sell |
25,066
-2,678
| -10% | -$47.9K | ﹤0.01% | 1273 |
|
|
2021
Q2 | $677K | Buy |
27,744
+6,942
| +33% | +$169K | ﹤0.01% | 1300 |
|
|
2021
Q1 | $551K | Buy |
20,802
+377
| +2% | +$9.99K | ﹤0.01% | 1377 |
|
|
2020
Q4 | $155K | Buy |
20,425
+3,015
| +17% | +$22.9K | ﹤0.01% | 1915 |
|
|
2020
Q3 | $87K | Sell |
17,410
-321
| -2% | -$1.6K | ﹤0.01% | 1537 |
|
|
2020
Q2 | $106K | Buy |
17,731
+4,693
| +36% | +$28.1K | ﹤0.01% | 1565 |
|
|
2020
Q1 | $58K | Sell |
13,038
-8,956
| -41% | -$39.8K | ﹤0.01% | 1110 |
|
|
2019
Q4 | $209K | Sell |
21,994
-3,546
| -14% | -$33.7K | ﹤0.01% | 1565 |
|
|
2019
Q3 | $200K | Sell |
25,540
-1,402
| -5% | -$11K | ﹤0.01% | 1445 |
|
|
2019
Q2 | $424K | Sell |
26,942
-3,617
| -12% | -$56.9K | ﹤0.01% | 1079 |
|
|
2019
Q1 | $553K | Buy |
30,559
+2,483
| +9% | +$44.9K | ﹤0.01% | 983 |
|
|
2018
Q4 | $451K | Buy |
+28,076
| New | +$451K | ﹤0.01% | 986 |
|